Porton Biopharma Limited
Manor Farm Road
Porton Down
Salisbury
Wiltshire
United Kingdom
Fax: 44-0-1980-612500
Website: http://www.portonbiopharma.com/
Email: business@portonbiopharma.com
About Porton Biopharma Limited
Porton Biopharma is based at Porton Down near Salisbury in Wiltshire. There is a long history of pharmaceutical development and manufacturing at the Porton Down site. Both Erwinase® and Anthrax Vaccine were developed here, as well as many other products (such as Dysport® and Voraxase® which have subsequently been out-licensed to other companies).YEAR FOUNDED:
2014
LEADERSHIP:
Managing Director: Roger Hinton
CAREER:
Please click here for Porton Biopharma's job opportunities.
PRODUCTS
Please click here for Porton Biopharma's products.
5 articles about Porton Biopharma Limited
-
PBL gains approval to advance next generation anthrax vaccine to Phase 1 clinical trial
10/22/2019
Porton Biopharma Ltd has announced that it has signed a modification to its contract with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases to advance a next generation intra-nasal anthrax vaccine into the clinical-trial phase.
-
Porton Biopharma opens new facility to make more of its childhood cancer cure
4/30/2018
John Glen MP for Salisbury and South Wiltshire today (27th April 2018) officially opened Porton Biopharma Limited’s (PBL) new fermentation facility which will be used to manufacture the company’s life-saving leukaemia drug Erwinase®.
-
Porton Biopharma Opens New Pharmaceutical Development Labs
6/30/2017
-
Porton Biopharma Gains Approval To Advance Next Generation Anthrax Vaccine
6/19/2017
-
NanoBio Corporation And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine
6/19/2017